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Abstrak
Latar belakang: Manifestasi klinis demam berdarah Dengue (DBD) adalah kebocoran plasma dan 
trombositopenia. Salah satu teori penyebab kedua hal tersebut adalah kadar trombin yang meningkat 
akibat aktivasi koagulasi. Kadar trombin dapat diwakili oleh kadar F1.2. Tujuan penelitian ini adalah untuk 
mengetahui hubungan antara kadar F1.2 dengan kebocoran plasma dan trombositopenia pada infeksi Dengue. 
Metode: Desain penelitian ini adalah potong lintang, mengggunakan plasma EDTA dari pasien terinfeksi 
virus Dengue. Subyek penelitian adalah 10 subyek dengan kebocoran plasma dan 10 subyek tanpa 
kebocoran plasma pada infeksi Dengue, 6 sampel berpasangan untuk perbandingan fase kritis dan fase 
konvalesen, 26 sampel untuk uji korelasi antara kadar F1.2 dengan jumlah trombosit. 
Hasil: Penelitian menunjukkan kadar F1.2 pada pasien terinfeksi virus Dengue dengan kebocoran plasma 
(rerata ± 2SD) 147,4 ± 105,82 pg/mL  lebih tinggi secara bermakna dibanding tanpa kebocoran plasma 
51,3 ±39,92 pg/mL. Kadar F1.2 pada fase kritis dengan median 186,3 (108,6-223,2)  pg/mL lebih tinggi 
secara bermakna dibanding fase konvalesen 46,5 (27,4-51,9) pg/mL. Terdapat korelasi negatif yang 
bermakna dengan kekuatan sedang antara kadar F1.2 dengan jumlah trombosit, nilai  r = - 0,609. 
Simpulan: Terdapat peningkatan aktivasi koagulasi yang ditunjukkan dengan peningkatan kadar F1.2 
pada fase kritis, berkaitan dengan kebocoran plasma dan trombositopenia pada pasien terinfeksi virus 
Dengue. (Health Science Journal of Indonesia 2016;7:37-43)
Kata kunci: infeksi Dengue, kebocoran plasma, trombin, fragmen protrombin (F1.2), trombositopenia
Abstract
Background: Clinical manifestations of Dengue hemorrhagic fever are plasma leakage and 
thrombocytopenia. Both manifestations are thought to be caused by an increased thrombin level due to 
activation of coagulation. The aim of this study is to look for any association between F1.2 level and 
plasma leakage and also between F1.2 level and thrombocytopenia in Dengue infected patients. 
Methods: This study used EDTA plasma from patients infected with Dengue virus. The study design 
was cross sectional. The thrombin level was represented by the prothrombin fragment 1.2 (F1.2) level. 
Twenty subjects were enrolled in this study, consisted of 10 subjects with plasma leakage and 10 without 
plasma leakage, 6 pairs of samples in critical phase and convalescent phase, 26 samples for correlation test 
between F1.2 level and platelet count. 
Results: In this study, it was found that the F1.2 level in patients with plasma leakage  (mean ± 2 SD) 
147.4 ± 105.82 pg/mL is significantly higher compared to patients without plasma leakage 51.3 ±39.92 pg/
mL, and the F1.2 level in critical phase has a median of 186.3 (108.6-223.2) pg/mL which is significantly 
higher compared to convalescent phase 46.5(27.4-51.9) pg/mL. Also it was found that a medium negative 
correlation between F1.2 level and the thrombocyte count existed, r = - 0.609. 
Conclusion: The results of the study suggest that there was increased coagulation activation at critical 
phase in patients infected with Dengue virus associated with plasma leakage and thrombocytopenia. 
(Health Science Journal of Indonesia 2016;7:37-43)
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Dengue fever is a disease transmitted by Aedes 
aegypti and Aedes albopictus infected with dengue 
virus of the family Flaviviridae. There are 4 dengue 
virus serotypes which are DENV-1, DENV-2, DENV-
3 and DENV-4.1 Dengue infection is a dangerous 
disease, mortality rate is 2.5 %, especially in children 
less than 15 years old. There are approximately 50 
million new cases each year. Of these there are about 
500 thousand people with dengue hemorrhagic fever 
(DHF), which requires hospitalization. WHO report 
stated there was a rise in dengue cases and number of 
deaths from 1985 until 2009. In Indonesia in 2009, 
156 062 cases of dengue were reported, while the 
number of deaths from dengue in that year is 1396.2
Clinical manifestations of dengue hemorrhagic fever 
are plasma leakage and bleeding that can lead to 
shock and death. There are various theories about the 
cause of plasma leakage. Plasma leakage is thought 
to be caused by increased capillary permeability. 
Increase in capillary permeability can be caused by 
Dengue virus itself, the immune response associated 
with the presence of viral proteins that are expressed 
by infected cells, and the immune responses 
associated with memory T cells, expressing much 
proinflammatory cytokines such as  TNF-α, IL-1, 
IL-6, IL-8.1,3,4 Increased levels of proinflammatory 
cytokines in the blood trigger the activation of 
the vascular endothelial. Activated endothelial 
will expresses tissue factor. Further,  tissue factor 
activates coagulation via extrinsic pathway.2, 5-7
Thrombin generation occurs after the activation of 
the coagulation cascade, forming prothrombinase 
that cuts prothrombin to thrombin and prothrombin 
fragment 1+2 (F1.2). F1.2 can be used as a marker 
of activation of coagulation and represented 
thrombin generation. Thrombin can accelerate its 
own generation and also can activate endothelial 
cellandplatelet.8Thrombin can activate protease 
activating receptor (PAR) 1, 3, 4 on endothelial cells. 
PAR activation will trigger the signal transduction, 
leading to increased capillary permeability and 
resulting in plasma leakage.9,10 Thrombin can also 
activate platelets through PAR 1 and 4 on platelets. 
Platelet activation causes excessive platelet 
aggregation, which leads to thrombocytopenia.3,11 
Thrombocytopenia may facilitate bleeding.1 Free 
thrombin will soon be neutralized by antithrombin 
and forms thrombin antithrombin complexes.12
The aim of the study was to compare the levels of 
F1.2 on a group of patients without and with plasma 
leakage, to compare the levels of F1.2 at a critical 
phase and convalescent phase in patients with plasma 
leakage and to look for correlation between F1.2 
levels and platelets number in Dengue virus infected 
patients. F1.2 represented thrombin generation.
METHODS
Patients
This study was approved by the Research Ethics 
Committee of the Faculty of Medicine, University 
of Indonesia and the Cipto Mangunkusumo Hospital 
institutional review board. The study design was 
cross-sectional with modification. The study was 
conducted in Cipto Mangunkusumo Hospital in 
January-September 2013. Twenty subjects were 
enrolled in this study, consisted of 10 subjects with 
plasma leakage and 10 without plasma leakage, 6 
pairs of samples in critical phase and convalescent 
phase, 26 samples for correlation test between F1.2 
level and platelet count. The diagnosis of dengue 
fever or dengue hemorrhagic fever by the clinician 
were based on WHO criteria 2011, had one  positive 
dengue serology results (or more) (NS1 and or IgM/
IgG anti-dengue positive). Dengue hemorrhagic 
fever was differentiated from dengue fever in 
the subjects by the presence of plasma leakage 
and thrombocytopenia. In subjects with dengue 
hemorrhagic fever there were both plasma leakage 
and thrombocytopenia presence.2 The subjects were 
over 15 years old and gave informed consent. The 
study subjects also were examined with Rontgen or 
albumin level test to determine whether there was 
any evidence of plasma leakage. Evidence of plasma 
leakage was shown by at least one of these things : 
increased hematocrit ≥ 20 % from reference value of 
average population by age, sex, race or a decrease in 
hematocrit ≥ 20 % from subject’s baseline after fluid 
replacement therapy / volume, or evidence of pleural 
effusion and or ascites by Rontgen photo/USG, and or 
hypoproteinemia , which is expressed with albumin 
£ 3.5 g/dL.13 Subjects with infectious diseases other 
than dengue, taking oral anticoagulants, suffering 
from malignancy, tissue trauma/ surgery, with 
pregnancy, were not included in the study. Sampling 
was performed three times, first sampling conducted 
between day one until day three of fever/ acute 
phase, second sampling between day four until six 
of fever (critical phase), third sampling conducted 
at day seven of fever or later (convalescent phase). 
Anticoagulant used was K3 EDTA. Blood with EDTA 
initially was examined by hematology analyzer to 
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get hematocrit and platelets count data. Level of 
F1.2 was analyzed using EDTA plasma which were 
centrifuged at a speed of 1000 g for 15 minutes at 
2-8oC. The plasma was separated within 4 hours 
since sampled.14 The plasma was stored at minus 
80OC (stable for 6 months). Hemolysis, icteric, and 
lipomic plasma were excluded from the study.
Plasma which was stored at -80OC, must be put 
at room temperature at least 30 minutes before 
analyzed, F1.2 test was done within 2 hours after 
thawing. Multiple freeze thawed was not allowed. 
Data of patient’s hematocrit value, albumin levels, 
thoracic X-ray were used to classify patients into 
groups with and without plasma leakage.
F1.2 level measurement
First, calibration curve was made, then within run 
precision test was done, after that the F1.2 levels 
were analyzed. The level of F1.2 was performed 
using reagents USCN Life Sciences. The principle 
of F1.2 test was sandwich enzyme immunoassay 
(ELISA). F1.2 in patient samples formed complex 
with monoclonal anti- F1.2 antibody precoated 
in wells. The complex was detected using biotin-
conjugated specific F1.2 antibodies. This complex 
was binded to avidin-conjugated with horse radish 
peroxidase (HRP). After TMB substrate solution is 
added, only those wells that contain F1+2, biotin-
conjugated antibody and enzyme-conjugated avidin 
will exhibit a change in color. The enzyme-substrate 
reaction is terminated by the addition of sulphuric 
acid solution and the color change is measured 
spectrophotometrically at a wavelength of 450 nm. 
The concentration of F1+2 in the samples is then 
determined by comparing the O.D. (optical density) 
of the samples to the calibration curve. The calibration 
curve was made  using Magellan computer program 
with logarithmic regression techniques.
Hematocrit value analysis
EDTA anticoagulated blood samples were analyzed 
by automated blood cell analyzer Sysmex XE-2100 
within 1 hour of sampling. The instrument used 
hydrodinamic focusing method and hematocrit value 
was calculated with pulse height RBC detection 
method. 
Platelet count
EDTA anticoagulated blood samples were analyzed 
by automated blood cell analyzer Sysmex XE-2100 
within 1 hour of sampling. The instrument used 
hydrodinamic focusing method and platelet count 
was calculated by impedance method.
Albumin level measurement
Serum samples were analyzed by automated clinical 
chemistry analyzer, Cobas C 501 within 2 hours of 
sampling. The instrument used colorimetric method.
NS1 antigen rapid test 
Plasma EDTA was analyzed by immuno chroma-
tography method with SD diagnostic NS1 rapid test.
IgG/IgM anti Dengue rapid test
Plasma EDTA was analyzed by immunochroma-
tography method with SD diagnostic IgG/IgM anti 
Dengue rapid test.
Statistical analysis
The Statistical Product and Service Solutions (SPSS) 
ver. 17 was used for computation. The demographic 
data was presented descriptively. A two sided P-value 
<0.05 was considered statistically significant. 
Shapiro Wilk test was used to determine the 
distribution of the data. When the data was normally 
distributed, F1.2 levels differences between subjects 
with and without plasma leakage was analyzed by 
unpaired t test. If the distribution was not normal, 
it would be analyzed with the Mann - Whitney test. 
When the data was normally distributed, differences 
between critical phase, and convalescent phases 
were analyzed by paired t test. If the distribution was 
not normal, it would be analyzed with the Wilcoxon 
test. When the data was normally distributed, the 
correlation between platelet count and F1.2 levels 
was analyzed by Pearson correlation test. If the 
distribution was not normal, it would be analyzed by 
Spearman correlation test.
RESULTS
As an initial examination, the calibration curve was 
made  from 7 standard levels of F1.2 which is 1000 
pg/ml, 333.33 pg/ml, 111.11 pg/mL, 37.04 pg/mL, 
12.35 pg/mL, 4.12 pg/mL, and 1.37 pg/mL, plus a 
blank that contains only standard diluent so that the 
levels are 0 pg/ mL. Accuracy test was conducted 
using a sample of patients who were examined five 
times, CV was 9.5%. According to the insert kitof 
USCN Life Science, CV < 10 % means that the 
results can be accepted.
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Twenty subjects were enrolled in this study, consisted 
of 10 subjects with plasma leakage and 10 without 
plasma leakage, 6 pairs of samples in critical phase 
and convalescent phase, 26 samples for correlation 
test between F1.2 level and platelet count. Subject’s 
characteristics could be seen at table 1.
In this study, it was found that the F1.2 level in patients 
with plasma leakage (number of samples(n)=10, 
mean ± 2 SD) 147.4 ± 105.82 pg/mL is significantly 
higher compared to patients without plasma leakage 
(n=10) 51.3 ±39.92 pg/mL (Fig.1.), and the F1.2 level 
in critical phase (n=6) has a median of 186.3 (108.6-
223.2) pg/mL which is significantly higher compared 
to convalescent phase (n=6) 46.5(27.4-51.9) pg/mL 
(Fig 2.). Also it was found that a medium negative 
correlation between F1.2 level and the thrombocyte 
count existed (n=26),  r = - 0.609 (Fig 3).
Table 1. Respondent characteristics
Subject Number Male Female Ages (year) Platelet count(cell/µL)
Without plasma leakage 10 3 7 Median 30 (15-56) -
With plasma leakage 10 4 6 Median 25(15-67) -
Comparison between critical 
phase and convalescent phase 6 people, 12 samples 1 5 16-58 -
Correlation between F1.2 level 
with platelet count 26 samples 8 18 15-67 13 500-320 000
Figure 1.  Comparison between F1.2 levels in patient 
infected with Dengue virus, without and with 
plasma leakage.
Figure 2. F1.2 level in critical phase and convalescent phase
Figure 3. F1.2 level correlation with platelet count in subjects 
infected with Dengue virus
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DISCUSSION
The purpose of the study was to search whether 
there was association between increased pro-
duction of thrombin with plasma leakage and 
thrombocytopenia in patients infected with dengue 
virus. Thrombin levels were represented by the F1.2 
levels because thrombin was bound by anti-thrombin 
and thrombomodulin rapidly. The hypothesis in this 
study is when F1.2 levels increased, the plasma 
leakage and thrombocytopenia occurred in dengue 
virus infection.
In this study, the F1.2 levels assays within run 
precision performed 5 times in a row on the same 
day using one sample. F1.2 levels of test accuracy 
are not done because the control material for F1.2 
is not available. However the assay was done at 
the same time as the standard, so we can be sure 
of the accuracy. The coefficient of variation (CV) 
obtained was 9.5 %, lower than the limit stated in the 
leaflet (CV is < 10 %), so we concluded that the test 
results can be accepted.15 The F1,2 assay was done 
manually, highly dependent on operator skill, it can 
caused relatively high CV value.
Initially, we conducted a pilot study with 20 subjects 
consisting of 10 subjects with plasma leakage and 
10 subjects without leakage of plasma to obtain a 
combined standard deviation . After we calculated 
sample size for unpaired t test, the required sample 
size was 38 subjects with plasma leakage and 38 
subjects without plasma leakage. The number of 
samples collected still insufficient. However, the 
differences in F1.2 levels between the 2 groups in 
this study were significant.
Most subjects were female. According to WHO 
report for 6 Asian countries namely Malaysia, 
Philippines, Singapore, Laos, Cambodia, Sri Lanka, 
there was a tendency that Dengue virus infection 
in the population ≥ 15 years is more common in 
men.16 But study by Hung et al among 245 infants 
infected with virus dengue, there is no difference 
between gender on the incidence of DHF / DSS.17 
The difference in this study is likely due to limited 
number of subjects. The age of the study subjects 
was 15-67 years with a mean of 30 years in the group 
without leakage of plasma, while the median age of 
the group with plasma leakage is 25 years old.
Patients without plasma leakage usually come to the 
RSCM at the first day until the fourth day of fever, 
usually without thrombocytopenia, so the patients 
weren’t hospitalized. Patients with plasma leakage 
usually come to RSCM on days 4-6, referred from 
another hospital and were in critical phase, thus we 
couldn’t get acute phase samples from the group 
with plasma leakage. The convalescent phase sample 
from the group with plasma leakage was taken on 
day 7th of fever and thereafter. It was thought that 
F1.2 levels obtained described condition of the 
patients when recovered from illness.
Table 2. F1.2 levels comparison between studies
Researcher Research subjects N Method F1.2 level (nmol/L)
Bauer et al14, 18 Health population 31 RIA, polyclonal antibody 1,5±0,7
Hurstinget al18 Health population <44 
yrs old
278 ELISA, monoclonal antibody, 
Organon
0,21-2,78
Krishnamurtiet al19 Children with DF/DHF 
in Thailand (acute phase 
samples)
12 ELISA, monoclonal antibody, 
Enzygnost
DF 2,93±0,46
6 DHF1 4,3±0,84
15 DHF 2 3,6±0,37
3 DHF 3 3,82±0,85
Suhartiet al6 Children with Dengue 
shock syndrome
50 ELISA, monoclonal antibody, 
Enzygnost
At entry
3,2(1,2-14,2)
1st day of fever
2,6(0,9-40,8)
2nd day
2,7(0,8-21,4)
This study DF/DHF patients in 
Indonesia >15 yrs old 
10 ELISA, monoclonal antibody, 
USCN Life Sciences
Without plasma leakage
1,64 (0,36-2,94)
10 With plasma leakage  (critical phase)
4,72 (1,33-8,12)
6 With plasma leakage (convalecens phase)
1,4 (0,87-1,66)
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The mean F1.2 levels in the group with plasma 
leakage were significantly higher than the group 
without plasma leakage. This means an increase in 
coagulation activation in the critical phase of dengue 
virus infection resulting in leakage of plasma. 
Although according to the calculation of sample 
size, the sample is not sufficient, however, because 
the results showed significant differences that do not 
need to increase the number of samples.
Comparison of F1.2 levels of this study with other 
studies can be seen in Table 2 below. Because other 
researchers discussed the examination F1.2 levels 
using nmol/L, the results F1.2 levels in this study 
was converted to nmol/L, they were divided by the 
molecular weight of 31.2 kDa.
The range of F1.2 levels in the group without plasma 
leakage was similar to the healthy population. This 
means that the activation of coagulation in the 
group without plasma leakage similar to the healthy 
population. F1.2 levels in the group with plasma 
leakage in the critical phase was much increased 
compared to the group without plasma leakage, 
meaning here was an increase in the activation 
of coagulation. Then the coagulation activation 
decreased in convalescent phase, as evidenced by 
decreased levels of F1.2.
These results were comparable with Krishnamurti’s 
studies in which F1.2 levels in patients without 
leakage of plasma were lower than those in patients 
with DHF. Other studies in patients with DHF 
performed in pediatric patients, whereas this study 
used subjects aged ≥ 15 years. All research methods 
using ELISA method, except Bauer et al who used 
RIA. All the data above proved that there was 
activation of coagulation resulting in increased levels 
of thrombin in the critical phase, finally resulting in 
leakage of plasma. Thrombin can bind to PAR 1,3,4 
on vascular endothelial thereby increasing capillary 
permeability and result in plasma leakage.8
There are other studies that seemed to contradict the 
results of this study. Research by Orsi et al showed 
thrombin level’s mean in Dengue patients with 
bleeding was 22745 nm, in those without bleeding 
was 33675 nm and in healthy controls was 37534 
nm. The assay of thrombin level was done by kinetic 
method and read by fluorometer. Orsi et al concluded 
that there had been a thrombin production disruptions 
resulting in pendarahan,20 contrary to the conclusions 
of this study but it should be noted that the study 
patient samples were taken after the 5th day of fever 
while in this study, the samples from critically ill 
patients were taken on the 4th or 5th day of fever. The 
explanation, the levels of thrombin decreased after 
5th day of  fever as evidenced in this study,  F1.2 
levels decreased in the convalescent phase .
In this study, F1.2 levels in the critical phase was 
significantly greater than those at convalescent phase 
proved that in critical phase thrombin production 
increased and then decreased in the convalescent 
phase. Increased production of thrombin is likely to 
be one of the causes of plasma leakage.
Data levels of F1.2 in all groups were analyzed for 
correlation with platelet counts. Using the Spearman 
test, negative correlation was found between platelet 
counts and F1.2 levels significantly. The higher levels 
of F1.2 meant stronger activation of coagulation 
occurred and caused lower number of platelets. 
This provided evidence of the possible influence of 
thrombin as a cause of thrombocytopenia. This is 
consistent with the theory about stimulated platelet 
activation by thrombin via PAR receptors 1 and 4. 
Activation of platelets causes an increase in platelet 
aggregation that resulting intrombocytopenia.8, 21
In conclussion, the results of the study demonstrated 
that there was increased coagulation activation at 
critical phase in patients infected with Dengue virus, 
as shown by F1,2 as indicator, associated with plasma 
leakage and thrombocytopenia. We suggest to do 
research on the strength of association of other factors 
causing plasma leakage and thrombocytopenia in 
dengue virus infected patients.
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